GENEVA, May 16 -- GENVIRA BIOSCIENCES INC. (310 Hunt Club Rd.Suite 304Ottawa, Ontario K1V 1C1) filed a patent application (PCT/CA2024/051471) for "ONCOLYTIC VACCINIA VIRUS" on Nov 07, 2024. With publication no. WO/2025/097249, the details related to the patent application was published on May 15, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): WANG, Jiahu (810 Dalkena PlaceOttawa, Ontario K2J 0Y4)
Abstract:
The present invention provides genetically modified vaccinia virus which may be employed as an oncolytic viral vector, wherein the genetically modified vaccinia virus comprises a nucle...